We are all guilty at one point or another of getting into a silo when we categorize a patient, especially if that patient has a chronic, progressive disease such as glaucoma. I myself, a cornea specialist, tend to ignore ocular surface considerations when first treating a glaucoma patient. However, these are co-existing diseases and often require concurrent care.
The “diabetic eye exam” is a frequently discussed topic at optometric conferences. But I really don’t know why because no such thing exists. We can provide a comprehensive ophthalmic exam for a patient with diabetes in the absence of diabetic retinopathy using codes 920X4 as medical policy guidance provides. This, of course, is where the devil is in the details and where our ethics as providers come into play.
When optometric opportunities present themselves, we ODs are in a privileged situation—we can choose whichever seems most interesting and enjoyable. However, we must carefully weigh our interests with those of our patients. What opportunities will best serve our patient populations? Certainly myopia progression, dry eye disease and cataract surgery comanagement are on the rise in just about every practice. Other areas of growth, highlighted in this month’s issue, include age-related macular degeneration (AMD) and diabetes management.
Speakers have been announced for the inaugural Women In Optometry Summit, Flex Your Superpowers, on Wed., June 19.